Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

TransMedics Group Inc

TMDX
141,70
-1,70 (-1,19%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:25EDGAR2Form 144 - Report of proposed sale of securities
05/6/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202419:06EDGAR2Form 144 - Report of proposed sale of securities
31/5/202422:38EDGAR2Form SD - Specialized disclosure report
31/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202423:19EDGAR2Form 144 - Report of proposed sale of securities
29/5/202423:08EDGAR2Form 144 - Report of proposed sale of securities
28/5/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:15EDGAR2Form 8-K - Current report
17/5/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
15/5/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202416:55EDGAR2Form 144 - Report of proposed sale of securities
08/5/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:08EDGAR2Form 144 - Report of proposed sale of securities
07/5/202400:08EDGAR2Form 144 - Report of proposed sale of securities
06/5/202416:54EDGAR2Form 144 - Report of proposed sale of securities
30/4/202422:05PRNUSTransMedics Reports First Quarter 2024 Financial Results
16/4/202422:05PRNUSTransMedics to Report First Quarter 2024 Financial Results..
08/4/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
19/3/202421:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
06/3/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202420:23EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:06PRNUSTransMedics to Present at Upcoming March Investor..
28/2/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202422:19EDGAR2Form 8-K - Current report
26/2/202422:05PRNUSTransMedics Reports Fourth Quarter and Full Year 2023..
26/2/202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
16/2/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
12/2/202422:05PRNUSTransMedics to Report Fourth Quarter and Full Year 2023..
08/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:05EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:05EDGAR2Form 8-K - Current report
03/2/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202417:05EDGAR2Form 144 - Report of proposed sale of securities
29/1/202422:05EDGAR2Form 8-K - Current report
29/1/202421:50BWNew Innovation-Themed Whitepaper to Debut at the February..
22/1/202416:30BWInvestment Opportunities in the Innovation Economy Headline..
16/1/202422:05PRNUSTransMedics Reports Inducement Grants Under NASDAQ Listing..
03/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:05EDGAR2Form 8-K - Current report
02/1/202417:46EDGAR2Form 144 - Report of proposed sale of securities
19/12/202322:14EDGAR2Form 8-K - Current report
Apertura: 141,61 Min: 139,7769 Max: 144,73
Chiusura: 143,40

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network